Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Gains from Sales and Divestitures (2024 - 2025)

TransMedics' quarterly Gains from Sales and Divestitures came in at $1280.0 in Q4 2025, up 101.24% year-on-year from $636.06 in Q4 2024, and down 91.56% quarter-over-quarter from $15157.0 in Q3 2025.

TransMedics has reported Gains from Sales and Divestitures for 2 years, with the latest figure at $1280.0 in Q4 2025.

  • For the quarter ending Q4 2025, Gains from Sales and Divestitures rose 101.24% year-over-year to $1280.0; the trailing twelve-month figure through Dec 2025 stood at $1280.0 (up 101.24% YoY), and the FY2025 full-year result was $1280.0, up 101.24% from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 stood at $1280.0, down from $15157.0 in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $111419.0 in Q1 2025, with the low at -$103372.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 TransMedics 2.32 Bn 1.86 Bn 101.16 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1,280.00
Dec 31, 2025 1,280.00
Sep 30, 2025 15,157.00
Sep 30, 2025 15,157.00
Jun 30, 2025 18,893.00
Jun 30, 2025 18,893.00
Mar 31, 2025 111,419.00
Mar 31, 2025 111,419.00
Dec 31, 2024 -103,372.00
Dec 31, 2024 -103,372.00
Sep 30, 2024 15,004.00
Sep 30, 2024 15,004.00
Jun 30, 2024 17,772.00
Jun 30, 2024 17,772.00
Mar 31, 2024 58,044.00
Mar 31, 2024 58,044.00